StocktoriaOSR Health, Inc. OSRH
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
0/9
Piotroski F — financial health
1.04
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $2.9M | $3.5M | — | — | — |
| Gross profit | $592,905 | $811,236 | — | — | — |
| Operating income | -$18.3M | -$11.7M | -$1.8M | -$35,388 | -$3,308 |
| Net income | — | -$2.4M | $403,780 | -$35,388 | -$3,308 |
| Operating cash flow | -$4.3M | -$1.8M | -$818,766 | -$4,235 | -$461 |
| Total assets | $171.2M | $175.2M | $36.6M | $1.2M | $705,087 |
| Total liabilities | $44.2M | $32.0M | $4.1M | $1.3M | $707,207 |
| Shareholders' equity | $127.0M | $143.2M | $153.5M | -$37,508 | -$2,120 |
| Ratios | |||||
| Gross margin | 20.4% | 23.0% | — | — | — |
| Operating margin | -631.0% | -331.2% | — | — | — |
| Net margin | — | -68.3% | — | — | — |
| Return on assets | — | -1.4% | 1.1% | -2.9% | -0.5% |
| Return on equity | — | -1.7% | 0.3% | 94.3% | 156.0% |
| Debt / equity | — | 0.00× | — | — | — |
| Current ratio | 0.16 | 0.67 | 0.01 | 0.10 | 0.01 |
| Revenue growth | -17.7% | — | — | — | — |
Why these scores methodology →
Piotroski F-score: 0/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.04 (distress)
- Working capital / assets -0.084
- Retained earnings / assets -0.217
- EBIT / assets -0.107
- Equity / liabilities 2.874
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001840425 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.